Erard Anne-Catherine Durcey, Garnerin Philippe, Michel Martine, Peyrard Thierry, Clergue François
Service d'hématologie, HUG, Genève.
Rev Med Suisse. 2006 Nov 22;2(88):2680-3.
Transfusion safety, time for a new partnership between stake-holders Following heightened publicity surrounding contaminated blood products, increased control has been implemented concerning all aspects of transfusion, from blood donor to finished product. A quality control programme has been implemented allowing a substantial reduction in adverse events. Transfusion medicine mandates the application of safety measures and hemo-vigilance helps to identify major risk factors in relation to bedside processes. Indeed, Swissmedic demands the application of such quality controls in every health institution. Given the enormous resources implicated with controlling transfusion products, isn't it time that National health authorities collaborate with local services in order to set a coherent transfusion policy and investment plan?
利益相关者建立新伙伴关系的时候到了 在围绕受污染血液制品的宣传增多之后，输血的各个方面，从献血者到成品，都实施了加强管控措施。已实施质量控制计划，大幅减少了不良事件。输血医学要求采取安全措施，血液警戒有助于识别与床边操作相关的主要风险因素。事实上，瑞士药品监管局要求每个医疗机构都实施此类质量控制。鉴于控制输血产品涉及巨大资源，国家卫生当局难道不该与地方服务机构合作，制定连贯的输血政策和投资计划吗？
